Daniel J. Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniel J. Hu has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Celine Chaaya
Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA
3 shared publications Magdalena G. Krzystolik
Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA
3 shared publications- Sandra Hoyek
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA
3 shared publications Dean Eliott
Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA
2 shared publications- Efren Gonzalez
Department of Ophthalmology Boston Children's Hospital Boston Massachusetts USA
2 shared publications - Francisco Altamirano
Department of Ophthalmology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
2 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by SAGE Publications in Therapeutic Advances in Ophthalmology
- Vol. 17
Evaluating for pentosan polysulfate maculopathy at a single academic institution
Purpose: To report the practices and outcomes of ophthalmic evaluations for pentosan polysulfate sodium (PPS) maculopathy at a single institution. Methods: This study was conducted on patients of Massachusetts Eye and Ear who had documented PPS exposure and an ophthalmic encounter from 2019 through 2022. The main outcomes were examination components performed and identification of PPS maculopathy. Image analysis confirmed findings. Results: Thirty-seven patients were included. Of the initial encounters, optical coherence tomography (OCT) was documented for 29 (78.4%) patients, fundus autofluorescence (FAF) for 13 (35.1%), and color fundus photography (CFP) for 12 (32.4%). Four cases (10.8%) of PPS maculopathy were observed. Mean (range) duration of exposure was 17 (15–20), and mean (range) cumulative exposure was 2418 (2190–2628) mg. Maculopathy did not occur until after 15 years of exposure and greater than 2000 mg of cumulative exposure. Three cases (8.1%) of PPS maculopathy were evaluated following drug cessation over a mean of 18.3 months. Two cases (5.4%) of PPS maculopathy progression post-cessation over durations of 1.1 and 4.3 years were described. Conclusion: We found inadequate imaging and documentation of OCT, CFP, and FAF to evaluate for toxicity in patients with a history of current or past PPS exposure. This study contributes four cases of PPS maculopathy to the growing literature reporting the phenotypic spectrum of toxicity, including two cases of maculopathy progression following drug cessation. There is a need for evaluations post-cessation due to possible progression of maculopathy, so patients are not treated inappropriately for differential diagnoses.
- 1 July 2025
- Published by SAGE Publications in Therapeutic Advances in Ophthalmology
- Vol. 17
Open AccessEvaluating for pentosan polysulfate maculopathy at a single academic institution
Purpose: To report the practices and outcomes of ophthalmic evaluations for pentosan polysulfate sodium (PPS) maculopathy at a single institution. Methods: This study was conducted on patients of Massachusetts Eye and Ear who had documented PPS exposure and an ophthalmic encounter from 2019 through 2022. The main outcomes were examination components performed and identification of PPS maculopathy. Image analysis confirmed findings. Results: Thirty-seven patients were included. Of the initial encounters, optical coherence tomography (OCT) was documented for 29 (78.4%) patients, fundus autofluorescence (FAF) for 13 (35.1%), and color fundus photography (CFP) for 12 (32.4%). Four cases (10.8%) of PPS maculopathy were observed. Mean (range) duration of exposure was 17 (15–20), and mean (range) cumulative exposure was 2418 (2190–2628) mg. Maculopathy did not occur until after 15 years of exposure and greater than 2000 mg of cumulative exposure. Three cases (8.1%) of PPS maculopathy were evaluated following drug cessation over a mean of 18.3 months. Two cases (5.4%) of PPS maculopathy progression post-cessation over durations of 1.1 and 4.3 years were described. Conclusion: We found inadequate imaging and documentation of OCT, CFP, and FAF to evaluate for toxicity in patients with a history of current or past PPS exposure. This study contributes four cases of PPS maculopathy to the growing literature reporting the phenotypic spectrum of toxicity, including two cases of maculopathy progression following drug cessation. There is a need for evaluations post-cessation due to possible progression of maculopathy, so patients are not treated inappropriately for differential diagnoses.
- Open Access
- 30 April 2025
- Published by Elsevier in AJO International
- Vol. 2 (2)
Multimodal imaging analysis and structure-function correlation in patients exposed to pentosan polysulfate sodium
- 30 April 2025
- Published by Elsevier in AJO International
- Vol. 2 (2)
Open AccessMultimodal imaging analysis and structure-function correlation in patients exposed to pentosan polysulfate sodium
- Open Access
- 24 January 2025
- Published by Wolters Kluwer Health in Eye Banking and Corneal Transplantation
- Vol. 4 (1) , e0035
Refinement of the Graft-over-Host Technique in Penetrating Keratoplasty
Purpose: We describe a refinement of the graft-over-host technique that eliminates the open-sky phase and reduces the use of additional sutures beyond what is needed for the traditional open-sky technique. Methods: This study is a surgical technique description and retrospective case review. For surgical technique, first, trephinate the recipient cornea to 90% depth. Dissect the cornea button, preserving the cardinal attachments. Secure the donor disc over the recipient cornea button with cardinal sutures. Complete the dissection of the cardinal attachments on the underlying recipient cornea button. Slide the recipient cornea button out from under the donor cornea disc. Place additional sutures for the additional securitization of donor disc. For data collection and analysis of surgical outcomes, we conducted a retrospective chart review for 35 patients who underwent the traditional open-sky technique and 28 patients who underwent the graft-over-host technique. Results: There were no cases of intraoperative complications including suprachoroidal hemorrhage and vitreal prolapse between both open-sky and graft-over-host cohorts. There were no significant differences in visual acuity between the cohorts at 6-month and 1-year follow-ups. Conclusions: Although penetrating keratoplasty may be an increasingly less common surgery, the risks associated with the open-sky phase persist. Surgeons may consider using the graft-over-host technique described in this study to reduce intraoperative risk while minimizing suture utilization, tissue manipulation, and associated operative time.
- 24 January 2025
- Published by Wolters Kluwer Health in Eye Banking and Corneal Transplantation
- Vol. 4 (1) , e0035
Open AccessRefinement of the Graft-over-Host Technique in Penetrating Keratoplasty
Purpose: We describe a refinement of the graft-over-host technique that eliminates the open-sky phase and reduces the use of additional sutures beyond what is needed for the traditional open-sky technique. Methods: This study is a surgical technique description and retrospective case review. For surgical technique, first, trephinate the recipient cornea to 90% depth. Dissect the cornea button, preserving the cardinal attachments. Secure the donor disc over the recipient cornea button with cardinal sutures. Complete the dissection of the cardinal attachments on the underlying recipient cornea button. Slide the recipient cornea button out from under the donor cornea disc. Place additional sutures for the additional securitization of donor disc. For data collection and analysis of surgical outcomes, we conducted a retrospective chart review for 35 patients who underwent the traditional open-sky technique and 28 patients who underwent the graft-over-host technique. Results: There were no cases of intraoperative complications including suprachoroidal hemorrhage and vitreal prolapse between both open-sky and graft-over-host cohorts. There were no significant differences in visual acuity between the cohorts at 6-month and 1-year follow-ups. Conclusions: Although penetrating keratoplasty may be an increasingly less common surgery, the risks associated with the open-sky phase persist. Surgeons may consider using the graft-over-host technique described in this study to reduce intraoperative risk while minimizing suture utilization, tissue manipulation, and associated operative time.
- Open Access
- 16 January 2025
- Published by SAGE Publications in Therapeutic Advances in Ophthalmology
- Vol. 17
Timing of vitrectomy for treatment of endophthalmitis after intravitreal anti-VEGF injection: a systematic literature review of case reports and series
Objective: To perform a systematic literature review analyzing visual outcomes of immediate, early, and delayed vitrectomy in the treatment of acute endophthalmitis after intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. Methods: We conducted a literature search using the Ovid Medline, Embase.com, and Web of Science databases, and relevant articles were selected from original English papers published from 2005 to 2021. Inclusion criteria were studies reporting cases of acute post-anti-VEGF endophthalmitis, defined as occurring within 6 weeks of injection treatment. Exclusion criteria were pediatric cases and cases explicitly reported to be caused by injections of contaminated drugs. Risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal tool for case reports and case series. The study dataset for descriptive and statistical analysis comprised patient-level data extracted from included studies. The timing of vitrectomy compared were defined as (1) immediate vitrectomy as occurring within 24 h of endophthalmitis diagnosis; (2) early vitrectomy as occurring between 24 and 48 h of endophthalmitis diagnosis; (3) late vitrectomy as occurring after 48 h of endophthalmitis diagnosis. Primary outcome was final visual acuity following treatment with vitrectomy. Results: Twenty-five articles were published that met our inclusion and exclusion criteria for a total of 86 cases. Thirty-seven were immediate vitrectomy, 25 were early, and 24 were late vitrectomy treatment groups, respectively. We observed differences in final visual outcomes and in improvement from diagnosis to final visual acuity, with patients receiving immediate and late vitrectomy to have better final visual outcomes than those patients receiving early vitrectomy ( p < 0.005). Conclusion: Our results show that there may be an association between time to vitrectomy and visual outcomes. Immediate and late vitrectomy treatment groups had better visual outcomes than the early group. Our results were limited by the reliance on case reports and series and the paucity of data available specifying the timing of vitrectomy. Additional research is necessary to elucidate the effects of treatment timing in patients with endophthalmitis following anti-VEGF injection.
- 16 January 2025
- Published by SAGE Publications in Therapeutic Advances in Ophthalmology
- Vol. 17
Open AccessTiming of vitrectomy for treatment of endophthalmitis after intravitreal anti-VEGF injection: a systematic literature review of case reports and series
Objective: To perform a systematic literature review analyzing visual outcomes of immediate, early, and delayed vitrectomy in the treatment of acute endophthalmitis after intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. Methods: We conducted a literature search using the Ovid Medline, Embase.com, and Web of Science databases, and relevant articles were selected from original English papers published from 2005 to 2021. Inclusion criteria were studies reporting cases of acute post-anti-VEGF endophthalmitis, defined as occurring within 6 weeks of injection treatment. Exclusion criteria were pediatric cases and cases explicitly reported to be caused by injections of contaminated drugs. Risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal tool for case reports and case series. The study dataset for descriptive and statistical analysis comprised patient-level data extracted from included studies. The timing of vitrectomy compared were defined as (1) immediate vitrectomy as occurring within 24 h of endophthalmitis diagnosis; (2) early vitrectomy as occurring between 24 and 48 h of endophthalmitis diagnosis; (3) late vitrectomy as occurring after 48 h of endophthalmitis diagnosis. Primary outcome was final visual acuity following treatment with vitrectomy. Results: Twenty-five articles were published that met our inclusion and exclusion criteria for a total of 86 cases. Thirty-seven were immediate vitrectomy, 25 were early, and 24 were late vitrectomy treatment groups, respectively. We observed differences in final visual outcomes and in improvement from diagnosis to final visual acuity, with patients receiving immediate and late vitrectomy to have better final visual outcomes than those patients receiving early vitrectomy ( p < 0.005). Conclusion: Our results show that there may be an association between time to vitrectomy and visual outcomes. Immediate and late vitrectomy treatment groups had better visual outcomes than the early group. Our results were limited by the reliance on case reports and series and the paucity of data available specifying the timing of vitrectomy. Additional research is necessary to elucidate the effects of treatment timing in patients with endophthalmitis following anti-VEGF injection.
- 8 January 2025
- Published by Elsevier in Ophthalmology
- Vol. 132 (6) , 713-717
Evaluating the Utility of Initial Examinations in Retinopathy of Prematurity
- 8 January 2025
- Published by Elsevier in Ophthalmology
- Vol. 132 (6) , 713-717
Evaluating the Utility of Initial Examinations in Retinopathy of Prematurity